🇺🇸 Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 in United States

Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 (Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 in United States?

Medical University of Warsaw is the originator. The local marketing authorisation holder may differ — check the official source linked above.